BriaCell Therapeutics Corp.
BCTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001610820
No open-market purchases or sales by BriaCell Therapeutics Corp. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $1.58M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by BriaCell Therapeutics Corp. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for BriaCell Therapeutics Corp., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Lustig Marc | Director, 10% Owner | 2,542,935Indirect | May 20, 2024 | 0 |
| Williams William V. | President, CEO | – | Dec 28, 2022 | 0 |
| Bondarenko Jamieson | Chairman | 169,856 | Dec 28, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 20, 2024 (view filing) | May 14 | 6 daysLate | Lustig MarcDirector, 10% Owner | PPurchase | +902.9K | $2.22 | +$2.00M | +55.1%2.54M after | |
| May 20, 2024 (view filing) | May 14 | 6 daysLate | Lustig MarcDirector, 10% Owner | PPurchase | +902.9K | – | – | –902.9K after | Derivative |
| Dec 28, 2022 (view filing) | Dec 28 | Same day | Bondarenko JamiesonChairman | PPurchase | +28.0K | $4.58 | +$128.2K | +19.7%169.9K after | |
| Dec 28, 2022 (view filing) | Dec 23 | 5 days | Williams William V.President, CEO | PPurchase | +2.53K | $1.94 | +$4.91K | –29.8K after | Derivative |
| Dec 20, 2022 (view filing) | Dec 20 | Same day | Bondarenko JamiesonDirector | PPurchase | +22.0K | $5.35 | +$117.7K | +18.4%141.9K after |